1
|
Power A and Carter L: Osteochondroma of
the mandibular condyle: an unusual case of dentofacial asymmetry.
Dent Update. 42:369–370. 372:2015.PubMed/NCBI View Article : Google Scholar
|
2
|
Nagori SA, Jose A, Bhutia O and
Roychoudhury A: Undiagnosed mandibular condylar fractures causing
temporomandibular joint ankylosis: A problem in northern India.
Natl Med J India. 27:251–255. 2014.PubMed/NCBI
|
3
|
Durham J, McDonald C, Hutchinson L and
Newton JL: Painful temporomandibular disorders are common in
patients with postural orthostatic tachycardia syndrome and impact
significantly upon quality of life. J Oral Facial Pain Headache.
29:152–157. 2015.PubMed/NCBI View Article : Google Scholar
|
4
|
Sierwald I, John MT, Schierz O, Hirsch C,
Sagheri D, Jost-Brinkmann PG and Reissmann DR: Association of
temporomandibular disorder pain with awake and sleep bruxism in
adults. J Orofac Orthop. 76:305–317. 2015.PubMed/NCBI View Article : Google Scholar
|
5
|
Tosato JP, Caria PH, Gomes CA, Berzin F,
Politti F, Gonzalez TO and Biasotto-Gonzalez DA: Correlation of
stress and muscle activity of patients with different degrees of
temporomandibular disorder. J Phys Ther Sci. 27:1227–1231.
2015.PubMed/NCBI View Article : Google Scholar
|
6
|
Fang PK, Ma XC, Ma DL and Fu KY:
Determination of interleukin-1 receptor antagonist, interleukin-10,
and transforming growth factor-beta1 in synovial fluid aspirates of
patients with temporomandibular disorders. J Oral Maxillofac Surg.
57:922–928; discussion 928-929. 1999.PubMed/NCBI View Article : Google Scholar
|
7
|
de Bont LG, Boering G, Liem RS, Eulderink
F and Westesson PL: Osteoarthritis and internal derangement of the
temporomandibular joint: A light microscopic study. J Oral
Maxillofac Surg. 44:634–643. 1986.PubMed/NCBI View Article : Google Scholar
|
8
|
Shafer DM, Assael L, White LB and
Rossomando EF: Tumor necrosis factor-alpha as a biochemical marker
of pain and outcome in temporomandibular joints with internal
derangements. J Oral Maxillofac Surg. 52:786–791; discussion
791-792. 1994.PubMed/NCBI View Article : Google Scholar
|
9
|
Sandler NA, Buckley MJ, Cillo JE and Braun
TW: Correlation of inflammatory cytokines with arthroscopic
findings in patients with temporomandibular joint internal
derangements. J Oral Maxillofac Surg. 56:534–543; discussion
543-544. 1998.PubMed/NCBI View Article : Google Scholar
|
10
|
Sakamaki H, Ogura N, Kujiraoka H, Akiba M,
Abiko Y and Nagura H: Activities of plasminogen activator, plasmin
and kallikrein in synovial fluid from patients with
temporomandibular joint disorders. Int J Oral Maxillofac Surg.
30:323–328. 2001.PubMed/NCBI View Article : Google Scholar
|
11
|
Takahashi T, Kondoh T, Fukuda M, Yamazaki
Y, Toyosaki T and Suzuki R: Proinflammatory cytokines detectable in
synovial fluids from patients with temporomandibular disorders.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 85:135–141.
1998.PubMed/NCBI View Article : Google Scholar
|
12
|
de Bont LG and Stegenga B: Pathology of
temporomandibular joint internal derangement and osteoarthrosis.
Int J Oral Maxillofac Surg. 22:71–74. 1993.PubMed/NCBI View Article : Google Scholar
|
13
|
Kobayashi K, Jokaji R, Miyazawa-Hira M,
Takatsuka S, Tanaka A, Ooi K, Nakamura H and Kawashiri S: Elastin
derived peptides are involved in the processes of human
temporomandibular disorder by inducing inflammatory responses in
synovial cells. Mol Med Rep. 16:3147–3154. 2017.PubMed/NCBI View Article : Google Scholar
|
14
|
Chambers MG, Cox L, Chong L, Suri N, Cover
P, Bayliss MT and Mason RM: Matrix metalloproteinases and
aggrecanases cleave aggrecan in different zones of normal cartilage
but colocalize in the development of osteoarthritic lesions in
STR/ort mice. Arthritis Rheum. 44:1455–1465. 2001.PubMed/NCBI View Article : Google Scholar
|
15
|
Kumagai K, Suzuki S, Kanri Y, Matsubara R,
Fujii K, Wake M, Suzuki R and Hamada Y: Spontaneously developed
osteoarthritis in the temporomandibular joint in STR/ort mice.
Biomed Rep. 3:453–456. 2015.PubMed/NCBI View Article : Google Scholar
|
16
|
Glasson SS, Chambers MG, Van Den Berg WB
and Little CB: The OARSI histopathology initiative -
recommendations for histological assessments of osteoarthritis in
the mouse. Osteoarthritis Cartilage. 18 (Suppl 3):S17–S23.
2010.PubMed/NCBI View Article : Google Scholar
|
17
|
Valverde-Franco G, Pelletier JP, Fahmi H,
Hum D, Matsuo K, Lussier B, Kapoor M and Martel-Pelletier J: In
vivo bone-specific EphB4 overexpression in mice protects both
subchondral bone and cartilage during osteoarthritis. Arthritis
Rheum. 64:3614–3625. 2012.PubMed/NCBI View Article : Google Scholar
|
18
|
Nakamura H, Vo P, Kanakis I, Liu K and
Bou-Gharios G: Aggrecanase-selective tissue inhibitor of
metalloproteinase-3 (TIMP3) protects articular cartilage in a
surgical mouse model of osteoarthritis. Sci Rep.
10(9288)2020.PubMed/NCBI View Article : Google Scholar
|
19
|
Dreessen D and Halata Z: Age-related
osteo-arthrotic degeneration of the temporomandibular joint in the
mouse. Acta Anat (Basel). 139:91–96. 1990.PubMed/NCBI View Article : Google Scholar
|
20
|
He B, Wu JP, Chen HH, Kirk TB and Xu J:
Elastin fibers display a versatile microfibril network in articular
cartilage depending on the mechanical microenvironments. J Orthop
Res. 31:1345–1353. 2013.PubMed/NCBI View Article : Google Scholar
|
21
|
Duca L, Lambert E, Debret R, Rothhut B,
Blanchevoye C, Delacoux F, Hornebeck W, Martiny L and Debelle L:
Elastin peptides activate extracellular signal-regulated kinase 1/2
via a Ras-independent mechanism requiring both p110gamma/Raf-1 and
protein kinase A/B-Raf signaling in human skin fibroblasts. Mol
Pharmacol. 67:1315–1324. 2005.PubMed/NCBI View Article : Google Scholar
|
22
|
Houghton AM, Quintero PA, Perkins DL,
Kobayashi DK, Kelley DG, Marconcini LA, Mecham RP, Senior RM and
Shapiro SD: Elastin fragments drive disease progression in a murine
model of emphysema. J Clin Invest. 116:753–759. 2006.PubMed/NCBI View
Article : Google Scholar
|
23
|
Robinet A, Fahem A, Cauchard JH, Huet E,
Vincent L, Lorimier S, Antonicelli F, Soria C, Crepin M, Hornebeck
W, et al: Elastin-derived peptides enhance angiogenesis by
promoting endothelial cell migration and tubulogenesis through
upregulation of MT1-MMP. J Cell Sci. 118:343–356. 2005.PubMed/NCBI View Article : Google Scholar
|
24
|
Gabay C: Interleukin-6 and chronic
inflammation. Arthritis Res Ther. 8 (Suppl 2)(S3)2006.PubMed/NCBI View
Article : Google Scholar
|
25
|
Kaspiris A, Khaldi L, Chronopoulos E,
Vasiliadis E, Grivas TB, Kouvaras I, Dagkas S and Papadimitriou E:
Macrophage-specific metalloelastase (MMP-12) immunoexpression in
the osteochondral unit in osteoarthritis correlates with BMI and
disease severity. Pathophysiology. 22:143–151. 2015.PubMed/NCBI View Article : Google Scholar
|
26
|
Hou P, Troen T, Ovejero MC, Kirkegaard T,
Andersen TL, Byrjalsen I, Ferreras M, Sato T, Shapiro SD, Foged NT,
et al: Matrix metalloproteinase-12 (MMP-12) in osteoclasts: New
lesson on the involvement of MMPs in bone resorption. Bone.
34:37–47. 2004.PubMed/NCBI View Article : Google Scholar
|
27
|
Chandler S, Cossins J, Lury J and Wells G:
Macrophage metalloelastase degrades matrix and myelin proteins and
processes a tumour necrosis factor-alpha fusion protein. Biochem
Biophys Res Commun. 228:421–429. 1996.PubMed/NCBI View Article : Google Scholar
|
28
|
Fu JY, Lyga A, Shi H, Blue ML, Dixon B and
Chen D: Cloning, expression, purification, and characterization of
rat MMP-12. Protein Expr Purif. 21:268–274. 2001.PubMed/NCBI View Article : Google Scholar
|
29
|
Flannery CR, Little CB, Hughes CE, Curtis
CL, Caterson B and Jones SA: IL-6 and its soluble receptor augment
aggrecanase-mediated proteoglycan catabolism in articular
cartilage. Matrix Biol. 19:549–553. 2000.PubMed/NCBI View Article : Google Scholar
|
30
|
Tortorella MD and Malfait AM: Will the
real aggrecanase(s) step up: Evaluating the criteria that define
aggrecanase activity in osteoarthritis. Curr Pharm Biotechnol.
9:16–23. 2008.PubMed/NCBI View Article : Google Scholar
|
31
|
Stanton H, Rogerson FM, East CJ, Golub SB,
Lawlor KE, Meeker CT, Little CB, Last K, Farmer PJ, Campbell IK, et
al: ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and
in vitro. Nature. 434:648–652. 2005.PubMed/NCBI View Article : Google Scholar
|
32
|
Glasson SS, Askew R, Sheppard B, Carito B,
Blanchet T, Ma HL, Flannery CR, Peluso D, Kanki K, Yang Z, et al:
Deletion of active ADAMTS5 prevents cartilage degradation in a
murine model of osteoarthritis. Nature. 434:644–648.
2005.PubMed/NCBI View Article : Google Scholar : Erratum in: Nature
446, 102, 2007.
|
33
|
Ohshima S, Saeki Y, Mima T, Sasai M,
Nishioka K, Nomura S, Kopf M, Katada Y, Tanaka T, Suemura M, et al:
Interleukin 6 plays a key role in the development of
antigen-induced arthritis. Proc Natl Acad Sci USA. 95:8222–8226.
1998.PubMed/NCBI View Article : Google Scholar
|
34
|
Fosang AJ, Last K, Stanton H, Golub SB,
Little CB, Brown L and Jackson DC: Neoepitope antibodies against
MMP-cleaved and aggrecanase-cleaved aggrecan. Methods Mol Biol.
622:312–347. 2010.PubMed/NCBI View Article : Google Scholar
|
35
|
Legendre F, Bogdanowicz P, Boumediene K
and Pujol JP: Role of interleukin 6 (IL-6)/IL-6R-induced signal
tranducers and activators of transcription and mitogen-activated
protein kinase/extracellular. J Rheumatol. 32:1307–1316.
2005.PubMed/NCBI
|
36
|
Sasai M, Saeki Y, Ohshima S, Nishioka K,
Mima T, Tanaka T, Katada Y, Yoshizaki K, Suemura M and Kishimoto T:
Delayed onset and reduced severity of collagen-induced arthritis in
interleukin-6-deficient mice. Arthritis Rheum. 42:1635–1643.
1999.PubMed/NCBI View Article : Google Scholar
|